Furthermore, the miR-204-3p inhibitor abolished the apoptosis of sh-BCYRN1-treated CRC cells, whereas sh-KRAS relieved these phenomena (Fig. 7d). The gene discussed is KRAS; the disease is colorectal carcinoma.